Symbol="HALO"
AssetType="Common Stock"
Name="Halozyme Therapeutics Inc"
Description="Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California."
CIK="1159036"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11388 SORRENTO VALLEY ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4885328000"
EBITDA="332883000"
PERatio="27.08"
PEGRatio="-2.5"
BookValue="0.5"
DividendPerShare="0"
DividendYield="0"
EPS="1.37"
RevenuePerShareTTM="5.18"
ProfitMargin="0.258"
OperatingMarginTTM="0.38"
ReturnOnAssetsTTM="0.117"
ReturnOnEquityTTM="1.114"
RevenueTTM="704980000"
GrossProfitTTM="454205000"
DilutedEPSTTM="1.37"
QuarterlyEarningsGrowthYOY="-0.326"
QuarterlyRevenueGrowthYOY="0.383"
AnalystTargetPrice="48.56"
TrailingPE="27.08"
ForwardPE="23.47"
PriceToSalesRatioTTM="13.28"
PriceToBookRatio="81.58"
EVToRevenue="15.76"
EVToEBITDA="31.48"
Beta="1.22"
num_52WeekHigh="59.46"
num_52WeekLow="29.85"
num_50DayMovingAverage="33.9"
num_200DayMovingAverage="43.72"
SharesOutstanding="131680000"
DividendDate="None"
ExDividendDate="None"
symbol="HALO"
open="37.41"
high="37.83"
low="37.00"
price="37.10"
volume="708535.00"
latest_trading_day="2023-07-11"
previous_close="37.32"
change="-0.22"
change_percent="-0.5895%"
aroon_positive_momentum_days="2"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="1419192"
Change_recent_avg="-0.1"
Delta_recent_avg="1.31"
Variance_recent_avg="0.65"
Change_ratio_recent_avg="-0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="120"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0056.jpeg"
image_negative_thumbnail_id_2="139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0037.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="611"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0097.jpeg"
image_positive_thumbnail_id_2="697"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0011.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
